# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-025611
Filing Date
2024-08-08
Accepted
2024-08-08 17:12:51
Documents
74
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | sava20240630_10q.htm iXBRL | 10-Q | 1004992
2 | EXHIBIT 31.1 | ex_677282.htm | EX-31.1 | 13774
3 | EXHIBIT 31.2 | ex_677283.htm | EX-31.2 | 13869
4 | EXHIBIT 32.1 | ex_677284.htm | EX-32.1 | 7623
10 |  | a03.jpg | GRAPHIC | 49207
11 |  | cab1ac4300e0img001.jpg | GRAPHIC | 28347
12 |  | chart_2.jpg | GRAPHIC | 71417
13 |  | fig5.jpg | GRAPHIC | 41195
14 |  | figure01.jpg | GRAPHIC | 19318
15 |  | figure03.jpg | GRAPHIC | 20580
16 |  | figure04.jpg | GRAPHIC | 12107
17 |  | figure4b02.jpg | GRAPHIC | 22157
18 |  | figure5b02.jpg | GRAPHIC | 26019
19 |  | slide05.jpg | GRAPHIC | 45320
| Complete submission text file | 0001437749-24-025611.txt |  | 5787282

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | sava-20240630.xsd | EX-101.SCH | 48301
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | sava-20240630_cal.xml | EX-101.CAL | 33635
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | sava-20240630_def.xml | EX-101.DEF | 286055
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | sava-20240630_lab.xml | EX-101.LAB | 261285
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | sava-20240630_pre.xml | EX-101.PRE | 316531
77 | EXTRACTED XBRL INSTANCE DOCUMENT | sava20240630_10q_htm.xml | XML | 732239

Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41905 | Film No.: 241189601
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)